alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
STATE of North Carolina v. Edwards Dean BELTON.

No. 542P04.

Supreme Court of North Carolina.

December 2, 2004.

Edward Dean Belton, Pro Se.

William P. Hart, Special Deputy Attorney General, R. Stuart Albright, District Attorney, for State of NC.

***ORDER***

Upon consideration of the petition filed by Defendant on the 14th day of October 2004 in this matter for a writ of certiorari to review the order of the North Carolina Court of Appeals, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

> "Dismissed by order of the Court in conference, this the 2nd day of December 2004."
EXHIBIT 10.25


 





Prof. Dr. med. Oliver Wiedow, Forstweg 55,
D-24105 Kiel, Germany


 


Kiel, on August 2, 2019


Proteo, Inc.


Att:     Chief Executive Officer 



Mr. Oliver Wiedow


2102 Business Center Drive


Irvine, CA 92612


USA


 



	Re: 	Elafin License Agreement 


 


This is to confirm certain agreements and understandings
reached between me and Proteo, Inc. in June 2019 based on the following background:


 


Pursuant to the provisions of the license agreement
between Proteo, Inc. (hereinafter “Licensee“) and myself (hereinafter “Licensor“; Licensee and Licensor
collectively the “Parties”) dated December 30th, 2000 as amended on December 23rd, 2008 (hereinafter
the “License Agreement“), Licensee promised to pay an aggregate amount of 660,000 Euros in certain installments to
Licensor. In December 2007, December 2008 and February 2012, Licensee paid to Licensor 30,000 Euros per year and no other payments
were made under the License Agreement to Licensor as of June 10th, 2014. In December 2012, Licensor agreed in writing
to waive the non-payment defaults and agreed to defer the due dates of the payments for the outstanding balance of 570,000 Euro
with installments due on April 15, 2015 (330,000 €), on December 31, 2015 (120,000 €) and on December 31, 2016 (120,000
€). In June 2014, Dr. Wiedow agreed in writing to defer the due date of the payments for the outstanding balance of 570,000
Euro to April 2018, and in March 2017 Dr. Wiedow agreed to defer the payment to June 30, 2020.


 


I herewith confirm that based on the foregoing
we have agreed on the following in June 2019:


 


	 	1. 	The Parties herewith agree that Licensor defers to November 15, 2020 the total amount of 570,000 Euros payable by Licensee, which otherwise would be due on June 30, 2020 (hereinafter the “Deferral”). 


 


	 	2. 	In the event that the Company's financial condition improves, the Parties would endeavor to enter in good faith negotiations to accelerate the payments. 


 


	 	3. 	Neither the Deferral under Section 1 hereof nor the willingness to negotiate accelerated payments as provided for in Section 2 hereof, would constitute a waiver of or estoppel to Licensor ‘s rights to already existing or future payment obligations under the License Agreement. 


 


Please confirm by respective countersignature
that you are in agreement with this letter and with this confirmation of our agreement from June 2019.


 


Kind regards,


 


/s/ Oliver Wiedow 


Prof. Dr. Oliver Wiedow


 


 


We agree to the foregoing


 


Proteo, Inc., on August 2, 2019


 


/s/ Oliver Wiedow 


Prof. Dr. Oliver Wiedow, Chief Executive Officer
Exhibit






2019 DECLARATION OF AMENDMENT TO
INCENTIVE AWARD PLAN OF
TANGER FACTORY OUTLET CENTERS, INC.
AND
TANGER PROPERTIES LIMITED PARTNERSHIP


THIS 2019 DECLARATION OF AMENDMENT (the “Amendment”) is made effective as of the 29th day of March, 2019 (the “Amendment Date”), by Tanger Factory Outlet Centers, Inc., a corporation organized under the laws of the State of North Carolina (the “Company”), and Tanger Properties Limited Partnership, a partnership organized under the laws of the State of North Carolina (the “Partnership”), to the Incentive Award Plan of the Company and the Partnership (Amended and Restated as of April 4, 2014), as amended on January 1, 2018 and as may be further amended from time to time (the “Plan”).  Capitalized terms used but not otherwise defined herein shall have the meanings assigned in the Plan.


RECITALS:


WHEREAS, the Company and the Partnership maintain the Plan;


WHEREAS, pursuant to Section 11.2 of the Plan, the Plan may be amended at any time and from time to time by the Board or the Committee; provided that approval by the Company’s shareholders is required for any amendment to the Plan that increases the number of shares which may be issued under the Plan (other than certain adjustments under the Plan); and


WHEREAS, the Board has deemed it advisable and in the best interests of the Company and the Partnership to amend the Plan as described herein.


NOW, THEREFORE, THE BOARD HAS DECLARED that, subject to the approval of the shareholders of the Company, the Plan shall be amended as follows:


		
	1.
	The first sentence of Section 2.1(a) of the Plan is hereby amended and restated in its entirety as follows: 


“Subject to Section 2.2 and adjustment pursuant to Section 11.3, the aggregate number of Common Shares which may be issued with respect to Awards under the Plan shall not exceed 18,700,000.”     











		
	2.
	This Amendment is adopted by the Board on the Amendment Date, effective as of the date of its approval by the shareholders of the Company within twelve (12) months following the Amendment Date (such date, the “Effective Date”). To the extent this Amendment is not approved by the shareholders of the Company within twelve (12) months following the Amendment Date, it shall be of no force and effect.  


		
	3.
	Upon the Effective Date, this Amendment shall be incorporated in and form a part of the Plan.


		
	4.
	Except as set forth herein, the Plan shall remain unchanged and in full force and effect following the Amendment Date.




[Signatures Follow on Next Page]
























IN WITNESS WHEREOF, this Amendment is executed on behalf of the Company and the Partnership on the Amendment Date, effective as of the Effective Date.






	
			
	 

	 
	 
	 

	 
	TANGER FACTORY OUTLET CENTERS, INC.



	 
	 
	 

	 
	By:
	/s/ James F. Williams

	 
	Name:
	James F. Williams

	 
	Title:
	EVP, Chief Financial Officer

	 
	 
	 

	 
	TANGER PROPERTIES LIMITED PARTNERSHIP



	 
	By:
	/s/ Chad D. Perry

	 
	Name:
	Chad D. Perry

	 
	Title:
	Vice President & Secretary
SMITH BARNEY MUNI FUNDS
(Florida, Georgia, Limited Term, National, New York and Pennsylvania 
Portfolios)
SMITH BARNEY INTERMEDIATE MUNICIPAL FUND, INC.
SMITH BARNEY MUNICIPAL FUND, INC.
(the "Funds")

Supplement dated December 19, 1996 to the Prospectuses*


Each Fund's Board of Directors/Trustees has approved the addition of zero 
coupon bonds to the list of authorized investments.  A zero coupon bond pays 
no interest in cash to its holder during its life, although interest is 
accrued during that period.  Its value to an investor consists of the 
difference between its face value at the time of maturity and the price for 
which it was acquired, which is generally an amount significantly less than 
its face value (sometimes referred to as a "deep discount" price).  Because 
such securities usually trade at a deep discount, they will be subject to 
greater fluctuations of market value in response to changing interest rates 
than debt obligations of comparable maturities which make periodic 
distributions of interest.  On the other hand, because there are no periodic 
interest payments to be reinvested prior to maturity, zero coupons securities 
eliminate the reinvestment risk and lock in a rate of return to maturity

____________________
*Prospectuses dated:

Smith Barney Muni Funds-(Georgia, National and Pennsylvania Portfolios)        
July 1, 1996
Smith Barney Muni Funds-(Florida, Limited Term and New York Portfolios)        
July 29, 1996 
Smith Barney Intermediate Municipal Fund, Inc.                                 
March 29, 1996
Smith Barney Municipal Fund, Inc.                                              
March 29, 1996


FD      


g/funds/sbfi/misc/multiskr
# FILED March 12, 1999 Cecil Crowson, Jr. Appellate Cou rt Clerk 

### IN THE COURT OF APPEALS OF TENN ESSEE

AT NASHVILLE
DONALD E. GRIFFIN, ) ) Plaintiff/Appellant, ) ) Appeal No. ) 01-A-01-9712-CH-00700 VS. ) ) Davidson Chancery ) No. 97-1104-I(II) SHELTER MUTUAL INSURANCE ) COMPANY, ) ) Defendant/Appellee. ) 

### ORD ER O N PE TITION TO R EHE AR The appellant has fileda petition to rehear which w e have considered and found to be without merit. It is, therefore, ordered that the petition is overrul ed.

______________________________________ BEN H. CANTRELL, PRESIDIN G JUDGE, M.S.

______________________________________ WILLIAM C. KOCH, JR., JUDGE

______________________________________ WILLIAM B. CAIN, JUDGE
110TH CONGRESS 

1ST SESSION H. R. 478

AN ACT

To designate the Federal building and United States courthouse located at 101 Barr Street in Lexington, Kentucky, as the ‘‘Scott Reed Federal Building and United 

States Courthouse’’.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

•HR 478 EH

1 SECTION 1. DESIGNATION. 

2 The Federal building and United States courthouse 

3 located at 101 Barr Street in Lexington, Kentucky, shall 

4 be known and designated as the ‘‘Scott Reed Federal 

5 Building and United States Courthouse’’. 

6 SEC. 2. REFERENCES. 

7 Any reference in a law, map, regulation, document, 

8 paper, or other record of the United States to the Federal 

9 building and United States courthouse referred to in sec10 tion 1 shall be deemed to be a reference to the ‘‘Scott 

11 Reed Federal Building and United States Courthouse’’. 

Passed the House of Representatives March 13, 

2007. 

Attest:

Clerk. 

110TH CONGRESS 

1ST SESSION H. R. 478

AN ACT

To designate the Federal building and United 

Building and United States Courthouse’’.Lexington, Kentucky, as the ‘‘Scott Reed Federal States courthouse located at 101 Barr Street in
Exhibit 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In  connection  with the  Quarterly  Report  of Green Mt.  Labs.,  Inc.(the
"Company")  on Form 10-QSB for the period  ending March 31, 2005,  as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
Geoff Williams,  Principal Accounting Officer of the Company,  certify, pursuant
to 18 U.S.C.  Sec. 1350, as adopted  pursuant to Sec. 906 of the  Sarbanes-Oxley
Act of 2002, that, to the best of my knowledge and belief:

     (1) The Report fully  complies  with the  requirements  of Section 13(a) or
     15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
     material respects,  the financial condition and result of operations of the
     Company.


/s/ Geoff Williams
------------------------------
Geoff Williams
Principal Accounting Officer
May 11, 2005

     A signed  original of this  written  statement  required by Section 906, or
     other document  authenticating,  acknowledging,  or otherwise  adopting the
     signature that appears in typed form within the electronic  version of this
     written  statement has been provided to the Company and will be retained by
     the Company and furnished to the Securities and Exchange  Commission or its
     staff upon  request.  The foregoing  certifications  are  accompanying  the
     Company's Form 10-QSB solely pursuant to section 906 of the  Sarbanes-Oxley
     Act of 2002  (subsections (a) and (b) of section 1350,  chapter 63 of title
     18,  United  States Code) and is not being filed as part of the Form 10-QSB
     or as a separate disclosure document.
Andrew MCWHORTER, Petitioner v. INDIANA

No. 19-6699

Supreme Court of the United States.

January 21, 2020

Petition for writ of certiorari to the Court of Appeals of Indiana denied.
To the Shareholders and Board of Directors of the
Travelers Corporate Loan Fund Inc.:

In planning and performing our audit of the financial statements of the
Travelers Corporate Loan Fund Inc. (the "Fund") for the year ended September
30, 2000, we considered its internal control, including control activities for
safeguarding securities, in order to determine our auditing procedures for the
purpose of expressing our opinion on the financial statements and to comply
with the requirements of Form N-SAR, not to provide assurance on the internal
control.

The management of the Fund is responsible for establishing and maintaining
internal control.  In fulfilling this responsibility, estimates and judgments
by management are required to assess the expected benefits and related costs
of controls.  Generally, controls that are relevant to an audit pertain to the
entity's objective of preparing financial statements for external purposes
that are fairly presented in conformity with generally accepted accounting
principles.  Those controls include the safeguarding of assets against
unauthorized acquisition, use, or disposition.

Because of inherent limitations in internal control, errors or fraud may occur
and not be detected.  Also, projection of any evaluation of internal control
to future periods is subject to the risk that it may become inadequate because
of changes in conditions or that the effectiveness of the design and operation
may deteriorate.

Our consideration of the internal control would not necessarily disclose all
matters in the internal control that might be material weaknesses under
standards established by the American Institute of Certified Public
Accountants.  A material weakness is a condition in which the design or
operation of one or more of the internal control components does not reduce to
a relatively low level the risk that misstatements caused by error or fraud in
amounts that would be material in relation to the financial statements being
audited may occur and not be detected within a timely period by employees in
the normal course of performing their assigned functions.  However, we noted
no matters involving the internal control and its operation, including
controls for safeguarding securities that we consider to be material
weaknesses as defined above.

This report is intended solely for the information and use of management, the
Board of Directors of the Fund, and the Securities and Exchange Commission and
is not intended to be and should not be used by anyone other than these
specified parties.



New York, New York
November 13, 2000
DePALMA v. ROMAN CATHOLIC DIOCESE OF RALEIGH

No. COA04-206.

Court of Appeals of North Carolina.

Filed December 7, 2004.

Certification Date December 28, 2004.

Case reported without published opinion. Affirmed.
<PAGE>

                                                                      Exhibit 32

      CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Annual Report of Riviera Tool Company (the
"Company") on Form 10-K for the period ending August 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), Kenneth K.
Rieth, Chief Executive Officer of the Company, and Peter Canepa, Chief Financial
Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

      (1)   The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

      (2)   The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company as of, and for, the periods presented in the Report.

Dated: April 15, 2005

By: /s/ Kenneth K. Rieth
    ------------------------------
        Kenneth K. Rieth
        Chief Executive Officer

Dated: April 15, 2005

By: /s/ Peter Canepa
    ------------------------------
         Peter Canepa
         Chief Financial Officer
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5019 Introduced in House (IH)]

110th CONGRESS
  2d Session
                                H. R. 5019

      To extend the temporary suspension of duty on Tralemethrin.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 16, 2008

Mrs. Tauscher introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
      To extend the temporary suspension of duty on Tralemethrin.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. TRALEMETHRIN.

    (a) In General.--Heading 9902.24.35 of the Harmonized Tariff 
Schedule of the United States is amended by striking ``12/31/2009'' and 
inserting ``12/31/2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
EXHIBIT 32.1

CERTIFICATION

In connection with the Quarterly Report on Form 10-Q of Helicos BioSciences Corporation (the "Company") for the
period ended June 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the "Report), we Stanley N. Lapidus, the Principal Executive Officer of the Company
and Stephen P. Hall, the Principal Financial and Accounting Officer of the Company, hereby certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, to our knowledge that:



Dated: August 14, 2008

/s/STANLEY N. LAPIDUSStanley N. Lapidus Chairman and Chief Executive Officer
(Principal Executive Officer)Dated: August 14, 2008

/s/STEPHEN P. HALLStephen P. Hall Senior Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)


---



QuickLinks
Exhibit 31.3**CERTIFICATIONS**I, Randy Underwood, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Dollar Financial Corp.;  2. Based on my knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect to theperiod covered by this report;  3. Based on my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, the periodspresented in this report;  4. The registrant’s other certifying officers and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) for the registrant and have: a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, to ensurethat material information relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;  b) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness ofthe disclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and  h) Disclosed in this report any change in the registrant’s internal controlover financial reporting that occurred during the registrant’s most recent fiscalquarter (the registrant’s fourth fiscal quarter in the case of an annual report)that has materially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and 5. The registrant’s other certifying officers and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of the registrant’s board of directors (or personsperforming the equivalent functions): a) All significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonably likelyto adversely affect the registrant’s ability to record, process, summarize andreport financial information; and  b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control overfinancial reporting.         Date:  May 9, 2006                               /*s/ Randy Underwood*        * *Randy Underwood        Executive Vice President andChief Financial Officer  
49
IN THE SUPREME COURT

STATE OF NORTH DAKOTA

2021 ND 180

State of North Dakota, Plaintiff and Appellee

v.

Barry Ryder Reddog, Defendant and Appellant

No. 20210055

Appeal from the District Court of Burleigh County, South Central Judicial 

District, the Honorable Bruce A. Romanick, Judge.

AFFIRMED.

Per Curiam.

Julie A. Lawyer, State’s Attorney, Bismarck, ND, for plainitff and appellee; 

submitted on brief.

Samuel A. Gereszek, Grand Forks, ND, for defendant and appellant.

FILED 

IN THE OFFICE OF THE 

CLERK OF SUPREME COURT 

OCTOBER 14, 2021 

STATE OF NORTH DAKOTA
1

State v. Reddog

No. 20210055

Per Curiam.

[¶1] Barry Reddog appealed from a criminal judgment entered after a jury 

convicted him of robbery with a firearm, destructive device, or other dangerous 

weapon and conspiracy to commit felonious restraint. He argues the evidence 

presented at trial is insufficient to support the jury’s verdict. After reviewing 

the record, we conclude substantial evidence supports the verdict. We 

summarily affirm under N.D.R.App.P. 35.1(a)(3).

[¶2] Jon J. Jensen, C.J.

Gerald W. VandeWalle

Daniel J. Crothers

Lisa Fair McEvers

Jerod E. Tufte